Drug Discovery & Development Intern — Undergrad/Master's

100 Eli Lilly and Company; Indianapolis (IN); On-site; USD 66,000 - 132,000; Full time

Benefits offered by this job

401(k) plan

Pension

Vacation benefits

Medical insurance

Dental insurance

Vision insurance

Prescription drug coverage

Flexible benefits

Life insurance

Employee clubs

Job summary

ELI LILLY AND COMPANY invites motivated students to join our Drug Discovery or Development teams at multiple sites in the United States, including Indianapolis. You will engage in bioassay development, compound testing, and synthesis while collaborating with world-class scientists.

We look for undergraduates or master's students with biology, chemistry, biochemistry, or pharmaceutics backgrounds, graduating by August 2027.

Qualifications

• Enrolled in an undergrad or master's program with a concentration in Biology, Chemistry, Biochemistry, Pharmaceutics, or a related discipline.
• Expected graduation by August 2027.
• Authorized to work in the United States on a full-time basis.

Responsibilities

• Bioassay development.
• Biological testing of compounds.
• Organic and Peptide synthesis.
• Chemical Modality and Molecular biology.
• Protein expression and purification, characterization.
• Analytical methods and formulation.
• Flow chemistry and project management.
• Drug product design and performance.
• Drug product manufacturing process development.

Skills

Bioassay development

Biological testing

Molecular biology

Project management

Communication skills

Education

Undergrad or Master’s program in Biology, Chemistry, Biochemistry, Pharmaceutics, or related discipline

Job description

ELI LILLY AND COMPANY invites motivated students to join our Drug Discovery or Development teams at multiple sites in the United States, including Indianapolis. You will engage in bioassay development, compound testing, and synthesis while collaborating with world-class scientists.

We look for undergraduates or master's students with biology, chemistry, biochemistry, or pharmaceutics backgrounds, graduating by August 2027.